ABOUT US
WHAT WE DO
CLINICAL TRIALS AND STUDIES
NEWS
CONTACT
More
AT MEDSIR WE ARE DEDICATED TO OFFER THE MOST RELEVANT NEWS ON THE LATEST ADVANCEMENTS IN ONCOLOGY CLINICAL RESEARCH. FIND OUT THE LATEST NEWS ON ONCOLOGY RESEARCH, REGULATORY APPROVALS, EVENTS, SCIENTIFIC CONFERENCES AND MUCH MORE!
Pembrolizumab may be the new standard of care for RCC with intermediate to high risk of recurrence
